Straumann Holding AG Income from Continuous Operations 2012-2024 | SAUHY
Straumann Holding AG annual/quarterly income from continuous operations history and growth rate from 2012 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
- Straumann Holding AG income from continuous operations for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
- Straumann Holding AG income from continuous operations for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
- Straumann Holding AG annual income from continuous operations for 2024 was $0.522B, a 89.85% increase from 2023.
- Straumann Holding AG annual income from continuous operations for 2023 was $0.275B, a 39.66% decline from 2022.
- Straumann Holding AG annual income from continuous operations for 2022 was $0.456B, a 4.29% increase from 2021.
Straumann Holding AG Annual Income from Continuous Operations
(Millions of US $) |
| 2024 |
$522 |
| 2023 |
$275 |
| 2022 |
$456 |
| 2021 |
$437 |
| 2020 |
$98 |
| 2019 |
$310 |
| 2018 |
$284 |
| 2017 |
$280 |
| 2016 |
$233 |
| 2015 |
$74 |
| 2014 |
$173 |
| 2013 |
$114 |
| 2012 |
$39 |
| 2011 |
$80 |
Straumann Holding AG Quarterly Income from Continuous Operations
(Millions of US $) |
| 2024-12-31 |
|
| 2024-06-30 |
|
| 2023-12-31 |
|
| 2022-12-31 |
|
| 2021-12-31 |
|
| 2021-06-30 |
|
| 2020-12-31 |
|
| 2020-06-30 |
|
| 2019-12-31 |
|
| 2018-12-31 |
|
| 2017-12-31 |
|
| 2017-06-30 |
|
| 2016-12-31 |
|
| 2016-06-30 |
|
| 2015-12-31 |
|
| 2014-12-31 |
|
| 2013-12-31 |
|
| 2013-06-30 |
|
| 2012-12-31 |
|
| 2012-06-30 |
|
| 2011-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED/DENTAL-SUPP |
$20.028B |
$2.845B |
|
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
|
